Skip to content
S1640Senate2015-2016 SessionSame asA4059

Includes within the schedules of controlled substances, any substances designated as controlled substances pursuant to the federal Analog Act and Controlled Substances Act

Sponsor Jeffrey D. KleinSD-34+8 co-sponsorsAffects Health
Status
In Assembly Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 5 of 7

In Assembly · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

History

  1. Referred to health
  2. Delivered to assembly
  3. Passed senateVote 61–0
  4. Ordered to third reading cal.50
  5. Committee discharged and committed to rules
  6. Print number 1640a
  7. Amend (t) and recommit to health
  8. Referred to health
  9. Returned to senate
  10. Died in assembly
  11. Referred to health
  12. Delivered to assembly
Show 5 earlier actions
  1. Passed senateVote 62–0
  2. Advanced to third reading
  3. 2nd report cal.
  4. 1st report cal.818
  5. Referred to health

Companion bill

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to including substances designated pursuant to the federal Analog Act and Controlled Substances Act within the definition of controlled substances

Purpose or general idea of bill

This bill will give state drug and law enforcement agencies and individuals the another tool to combat the quickly moving world of designer drugs. The Federal Analog Act (21 use § 813) allows scheduling and enforcement against drugs which are substantially structurally similar to those in schedule I or II. This bill will incorporate substances scheduled under this act into New York State Public Health Law.

Summary of specific provisions

Section 1 amends Public Health Law Section 3306 to incorporate the Federal Analog Act into New York State's Drug Scheduling provisions.

Justification

Currently under New York State Law, only a narrow selection of scheduled substances have analog protection. That is, manufacturers often only need to chemically "tweak" a drug to avoid scheduling. This creates a game of cat and mouse, with legislation and enforcement far slower to act than the manufacturers of designer drugs. On the federal level, the Drug Enforcement Agency is able to act on new, individual substances on a case-by-case basis through the use of the Federal Analog Act which schedules burgeoning substances "substantially similar to the chemical structure of a controlled substance in schedule or II." This legislation incorporates this act into Public Health Law 3306 to give state enforcement another tool.

Prior legislative history

2014 - S. 2447 - Passed Senate 2012 - S. 7102 Reported to Senate Calendar.

Fiscal implications

None to the State.

Effective date

This act shall take effect on the 180th day after it shall have become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.